Current status of platelet-rich plasma therapy under the act on the safety of regenerative medicine in Japan
Open Access
- 30 March 2023
- journal article
- review article
- Published by Elsevier in Regenerative Therapy
- Vol. 23, 37-43
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Irreversible Blindness Following Periocular Autologous Platelet-Rich Plasma Skin Rejuvenation TreatmentOphthalmic Plastic & Reconstructive Surgery, 2017
- Effects of Platelet Rich Plasma on Healing Rate of Long Bone Non-union Fractures: A Randomized Double-Blind Placebo Controlled Clinical Trial.2016
- Japan's challenges of translational regenerative medicine: Act on the safety of regenerative medicineRegenerative Therapy, 2016
- New Japanese Initiatives on Stem Cell TherapiesCell Stem Cell, 2015
- Investigating the Effect of Autologous Platelet-Rich Plasma on Pain in Patients With Pilonidal Abscess Treated With Surgical Removal of Extensive TissueIranian Red Crescent Medical Journal, 2013
- Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcersJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2007
- Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I: Technological concepts and evolutionOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2006
- Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcersJournal of Vascular Surgery, 2003
- The use of plasma-rich growth factors (PRGF) in oral surgery.2001
- Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants.1999